Cellerant Pipeline
What Are Stem Cells?
CLT-008 Universal Cell-Based Drug
For Neutropenia
For Acute Radiation Syndrome
Cancer Stem Cell Antibodies
 
Cellerant Pipeline

Cellerant has two major products under development:

  • CLT-008, an off-the-shelf cell-based medicine which can facilitiate engraftment in cord blood transplants (CBT) and treat neutropenia; and
  • Antibody therapy targeting Cancer Stem Cells.

 

Copyright ©2006-2011 Cellerant Therapeutics, Inc.
Site design by Birdsall Interactive
Our Affiliates